1 Mucolipidosis IV (MLIV) is an ultra-rare, recessively inherited lysosomal disorder resulting from inactivating mutations in MCOLN1, the gene encoding the lysosomal cation channel TRPML1. The disease primarily affects the central nervous system (CNS), and manifests in the first year with cognitive and motor developmental delay, followed by a gradual decline in neurological function across the second decade of life, blindness and premature death in third or fourth decades. Brain pathology manifestations in MLIV are consistent with hypomyelinating leukodystrophy with brain iron accumulation. Presently there are no approved or investigational therapies for MLIV and pathogenic mechanisms remain largely unknown. MLIV mouse model, Mcoln1-/- mice, recapitulate all major manifestations of the human disease. Here, to better understand brain pathological mechanisms of the disease, we performed cell type specific MS/MS proteomics analysis in MLIV mouse model and reconstituted molecular signatures of the disease in freshly isolated populations of neurons, astrocytes, oligodendrocytes and neural stem cells or whole tissue cortical homogenates from young adult symptomatic Mcoln1-/- mice. Our analysis confirmed on molecular level major histopathological hallmarks of MLIV, such as hypomyelination, lysosomal dysregulation, impaired metabolism of lipids and polysaccharides, universally present in Mcoln1-/- tissue and brain cells. Importantly, pathway analysis in brain cell datasets revealed mitochondria-related alterations in all Mcoln1-/- brain cells expect oligodendrocytes, that was not possible to resolve in whole tissue data set. We also report unique proteome signatures and dysregulated pathways for each brain cell population used in this study. These data shed new light on cell-intrinsic mechanisms of MLIV and provide new insights for biomarker discovery and validation to advance translational studies for this disease
[doi:10.25345/C5QV3CD6M]
[dataset license: CC0 1.0 Universal (CC0 1.0)]
Keywords: lysosomal disease, mucolipidosis, TRPML1, central nervous system, brain cells, cell specific proteomics, biomarkers
Principal Investigators: (in alphabetical order) |
Bogdan Budnik, Wyss Institute, Harvard University, United States |
Submitting User: | bbudnik |
Number of Files: | |
Total Size: | |
Spectra: | |
Subscribers: | |
Owner | Reanalyses | |
---|---|---|
Experimental Design | ||
Conditions:
|
||
Biological Replicates:
|
||
Technical Replicates:
|
||
Identification Results | ||
Proteins (Human, Remapped):
|
||
Proteins (Reported):
|
||
Peptides:
|
||
Variant Peptides:
|
||
PSMs:
|
||
Quantification Results | ||
Differential Proteins:
|
||
Quantified Proteins:
|
||
Browse Dataset Files | Browse Results |
FTP Download Link (click to copy):
|